Role of therapeutic apheresis in infectious and inflammatory diseases: Current knowledge and unanswered questions

15Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Apheresis can remove pathogens and mediators that contribute to pathogenic inflammatory responses in diseases not generally considered to be "Hematologic." Erythrocytapheresis can remove intracellular pathogens such as Babesiosis. Plasmapheresis can remove mediators of the inflammatory response in conditions such as sepsis, chronic autoimmune urticaria and malignant pertussis. Leukapheresis can remove potentially harmful leukocytes in Crohn's Disease and malignant pertussis. While apheresis can remove all of these substances, the clinical efficacy and pathophysiologic changes that occur during apheresis in these conditions are largely unknown. Hence, the clinical utility of apheresis in these conditions is largely unknown and research in these areas has the potential to benefit many patients with a variety of diseases.

Cite

CITATION STYLE

APA

Sloan, S. R., Andrzejewski, C., Aqui, N. A., Kiss, J. E., Krause, P. J., & Park, Y. A. (2015). Role of therapeutic apheresis in infectious and inflammatory diseases: Current knowledge and unanswered questions. Journal of Clinical Apheresis, 30(5), 259–264. https://doi.org/10.1002/jca.21370

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free